tiprankstipranks
Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ:AMLX
US Market
AMLX
Amylyx Pharmaceuticals Inc
RESEARCH TOOLSreports
Want to see AMLX full AI Analyst Report?

Amylyx Pharmaceuticals Inc (AMLX) Stock News & Sentiment

665 Followers
Amylyx Pharmaceuticals Charts Path to 2026 Trial Data
Premium
Company Announcements
Amylyx Pharmaceuticals Charts Path to 2026 Trial Data
23d ago
AMLX
Buy Rating Reiterated on Amylyx as Avexitide Progress and Cash Runway Support Upside vs. Unchanged $24 Price Target
Premium
Ratings
Buy Rating Reiterated on Amylyx as Avexitide Progress and Cash Runway Support Upside vs. Unchanged $24 Price Target
24d ago
AMLX
Amylyx’s ORION Trial in Progressive Supranuclear Palsy Reaches Completion: What Investors Should Watch
Premium
Company Announcements
Amylyx’s ORION Trial in Progressive Supranuclear Palsy Reaches Completion: What Investors Should Watch
1M ago
AMLX
Buy Rating on Amylyx: De-Risked Avexitide Phase III Study and Significant PBH Market Opportunity Support 2027 Launch Potential
Premium
Ratings
Buy Rating on Amylyx: De-Risked Avexitide Phase III Study and Significant PBH Market Opportunity Support 2027 Launch Potential
2M ago
AMLX
Amylyx Highlights Pipeline Progress in Updated Corporate Presentation
Premium
Company Announcements
Amylyx Highlights Pipeline Progress in Updated Corporate Presentation
2M ago
8K
AMLX
Buy Rating on Amylyx Pharmaceuticals Driven by Avexitide’s Commercial Potential and De-Risked Phase III PBH Program
Premium
Ratings
Buy Rating on Amylyx Pharmaceuticals Driven by Avexitide’s Commercial Potential and De-Risked Phase III PBH Program
3M ago
AMLX
Amylyx Pharmaceuticals Maps High-Stakes Path to 2027
Premium
Company Announcements
Amylyx Pharmaceuticals Maps High-Stakes Path to 2027
3M ago
AMLX
More AMLX News >

AMLX News on the Web

Insider Confidence Surges as Amylyx Director Boosts Personal Stake
TipRanks News
Neutral
Amylyx Stock: Why the Full Pipeline Story Matters
MarketBeat
Bullish
LifeSci Capital Remains a Buy on Amylyx Pharmaceuticals Inc (AMLX)
TipRanks News
Neutral
Amylyx announces publication of Phase 2 open-label HELIOS trial data
TipRanks News
Bullish
Amylyx Pharmaceuticals Eyes Phase 3 AVEXITIDE Readout as 2027 Launch Comes Into Focus
MarketBeat
Bullish
Amylyx Pharmaceuticals Inc at Bank of America Global Healthcare Conference Transcript
GuruFocus News
Neutral
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Analysts Have Conflicting Sentiments on These Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX), Hims & Hers Health (HIMS) and MBX Biosciences, Inc. (MBX)
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
AMLX
Sector Average
Media Buzz
This Week1 articles
Weekly Average5.75 articles
News Sentiment
This Week99%
Sector Average82%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AMLX’s Media Buzz Sentiment?
1 articles about AMLX were published this week. In an average week, 5.75 articles are published.
    What is AMLX’s weekly average amount of articles?
    In an average week, 5.75 articles about AMLX are published.
      What is AMLX’s News Sentiment?
      99% of articles about AMLX were positive this week, compared to its sector average of 82%.
        Healthcare Stocks that are Trending in the News
        AAgilent
        PHRPhreesia
        ADOAnteoTech Ltd
        OTLKOutlook Therapeutics
        IHHHFIHH Healthcare Bhd
        Showing the stocks with the most bullish news sentiment over the past week